(Endocrinol Japon 38: 287-295, 1991) THE RAT preoptic region contains an area or nucleus that exhibits sexual dimorphisms characterized by differences in regional nuclear volume and neuronal size, as well as dendritic length, branching patterns and spine distribution [1] [2] [3] . Such an area or nucleus, called the medial preoptic area (MPO) or sexually dimorphic nucleus, has been associated with at least some sexually differentiated functions such as behavior and gonadotropin secretion (see review by MacLusky and Naftolin [4] ). It has recently been suggested that the opioid system in the preoptic region is also sexually dimorphic.
The methionine-enkephalin fibers [5] and opioid receptors [6] [7] [8] are much more richly distributed in the female MPO. On the other hand, it has been reported that naloxone, an opioid receptor antagonist, acts at the MPO, as well as at the medial basal hypothalamus, and induces luteinizing hormone (LH) secretion in the female rat [9] . The purpose of this investigation was to examine whether there was sexual difference in the effect of naloxone injected into the MPO as well as the adjacent diagonal band of Broca (DBB) on LH and prolactin (PRL) secretion in rats. The DBB has played similar roles to the MPO in the control of gonadotropin secretion [10] [11] [12] , sharing LHreleasing hormone secreting neurons as the MPO [13. 14] . In this part of the preoptic region opioid receptors are densely aggregated, similarly to the MPO [ 15] and 1400h in order to assess the acute effects of naloxone, and at 1-h intervals afterwards until 2000 h. Samples at 1300h were taken just prior to the injection.
Naloxone-induced seizures
In the course of the sampling experiment in intact animals, we had occasionally discovered that the rat given a microinjection of naloxone in the MPO or the DBB very often showed signs of behavioral seizures. The stage of each seizure was then measured and recorded as described previously [17] . Briefly, the seizures were classified as follows: stage 0, no response or behavioral arrest; stage 1, rhythmic mouth and facial movement; stage 2, rhythmic head nodding; stage 3, forelimb clonus; stage 4, rearing and bilateral forelimb clonus; and stage 5, rearing and falling.
Further, gonadectomized rats were used to examine the effect of gonadal steroid hormones on the incidence of seizures, because it has been suggested that gonadal steroids are profoundly implicated in the control of opioid receptor content [18, 19] . In addition, in some rats, the cortical EEG was recorded via stainlesssteel screws fixed to the skull with dental cement, to ascertain whether the behavioral seizures accompanied EEG seizures.
Hormone assay Serum concentrations of LH and PRL were measured by the double-antibody radioimmunoassay with materials supplied by the NIDDK and expressed in terms of rat NIH-LH-Sl and NIH-PRL-RP1, respectively. All samples from both male and female experiments were measured in a single assay. For the male experiment, the minimally detectable amounts (95% confidence limits of buffer controls) of LH and PRL were 0.3 and 1.9 ng/ml, respectively. The intraassay coefficients of variation (CVs) estimated in 5 replicates of stock serum at the mean LH and PRL concentrations of 3.8 and 6.5ng/ml were 3.0 and 18.9%,. respectively. For the female experiment, the minimally detectable amounts of LH and PRL were 0.2 and 0.2ng/ml, respectively, and the intraassay CVs estimated at the mean LH and PRL concentrations of 4.6 and 13.7ng/ml were 5.6 and 19.1%, respectively.
After final bleeding at 2000 h, the animals were anesthetized with ether and perfused with 10% buffered formalin. The site of the injection was microscopically identified in frozen sections of the brain. The end of the cannula track was considered to be the site of the injection. without behavioral seizures had about a 2.5 times increase in serum LH 20min after the injection of naloxone, followed by a rapid decline to the preinjection level at 1h. In the rat that responded with behavioral changes, an increase in serum LH also occurred, but the peak value 20min after the injection was not significantly different from the value in the saline-injected animals at the corresponding time.
In animals given naloxone, regardless of whether they had behavioral seizures, the serum PRL 20min-2h after the injection was decreased significantly compared to that in saline-injected animals at corresponding times. Namely, there was no tendency to an afternoon increase in PRL in the naloxone-injected rats.
Discussion
One of the interesting findings in the present study was, although unexpected, that naloxone microinjected into the MPO and DBB elicited behavioral and EEG seizures in the rat. In spite of the well known convulsant action of opiate and opioid peptides [20] , naloxone has been reported to induce behavioral and EEG seizures in several species of animals [21] [22] [23] [24] , and was effective in inhibiting the post-ictal inhibition of kindled seizures [25] and in augmenting picrotoxin-induced seizures [26] in rats. Naloxone increased the severity of audiogenic seizures in mice [27] and the incidence of seizures in the genetically seizureprone gerbil [28] . These results have suggested the existence of a tonically active anticonvulsant system in the central nervous system, presumably mediated by endogenous opioids [20] , but all the results were obtained with systemic injection of naloxone. Therefore, the present finding extends the concept, first by demonstrating the site of action of naloxone in the brain.
The mechanism for the seizurogenic action of naloxone injected into the MPO and DBB is unclear. However, in view of the knowledge that this part of the DBB, i.e., the vertical limb, provides a source of cholinergic projections to the hippocampus [29] and that electrical stimulation Fig. 4 . Effects of an injection of saline or naloxone (NAL) at 1330h (arrow) on the serum concentration of LH and PRL in the male rat. The effect in rats that did not respond with behavioral seizures is shown separately (S-). Each point and the vertical bar represent the mean and S.E., respectively. The number in parenthesis is the number of animals. The solid symbol indicates that the value was significantly greater (p<0.01) than the value at 1330 h.*;p<0.001 or 0.05 vs saline-injected rats at corresponding times. of the site occupied by cholinergic neurons enhances the neocortical and hippocampal neuronal activity [30] [31] [32] [33] [34] , it is probable that naloxone somehow causes the activation of these cholinergic neurons. There is a report that microinjection of opiate and opioid in the forebrain produces EEG slow waves and spindling in rats [35] , suggesting that naloxone injected there may antagonize this opioid inhibition upon the cholinergic neurons. In addition, there is agreement that the seizurogenic action of naloxone is a result of GABA receptor blockade [23, 24, 36, 37] , and thus this GABA antagonism, too, is able to cause disinhibition of cholinergic neurons. Therefore, in the present study, the key area was likely to be the DBB, although the injection sites effective in inducing seizures were distributed widely in the MPO and The stimulation of LH secretion was produced in the present study by the injection of naloxone into the MPO and DBB in the female rat in diestrus, regardless of whether behavioral seizures occurred or not. The naloxone effect was somewhat different from that reported previously [9] . In our present study, LH peaked 20 min after the injection, followed by a rapid decline, whereas in Kalra's LH increased progressively for up to 2h. This may be mainly related to the difference in the hormonal environment of the animal, i.e., intact diestrous in the present study vs ovariectomized estrogen-progesterone primed in Kalra's, the latter corresponding to intact proestrus. In addition, Kalra [9] did not mention the behavioral seizures. If the rats used really did not develop seizures, the reason for this is unclear.
In the male rat, the same dose of naloxone as in the female rat produced a stimulatory effect on LH secretion quantitatively similar to that observed in the female rat. It may therefore be said that the sensitivity to naloxone of the neural mechanism controlling LH secretion, as evaluated by the magnitude of the effect exerted by naloxone on LH secretion, is similar in both male and female, at least in diestrus. Since such sensitivity is greatest on the days of estrus and diestrus [38, 39] , the opioid receptors or endogenous opioid concentrations in the male rat are considered comparable to those in the female rat on these days during the estrous cycle. In addition, the present results indicate that at least some of the opioid receptors concerned with LH secretion following the intraventricular [40] and subcutaneous [41, 42] injection of naloxone in the male rat are those, at least, located in the MPO and DBB.
In the female rat in diestrus, naloxone injection in the MPO and DBB caused an immediate decrease in PRL secretion. Systemic injection of naloxone has been reported to cause either a decrease on the day of estrus [43] or no effect on the days of diestrus [38, 42] . The present results clearly show that PRL secretion which is probably affected by the circadian rhythm is stimulated by an opioid mechanism within the preoptic region. In the male rat, intraventricular [38, 44] and subcutaneous [42] injection of naloxone failed to alter PRL secretion at least at 15-60 min. The present results are in agreement with these previous data. However, inhibition of the PRL rise in the later afternoon, which is assumed to correspond with the afternoon rise in the female, is likely to explain the previously reported decrease in PRL [43] and supports the concept that the PRL secretion in the male rat is also stimulated by an opioid mechanism in the preoptic region.
The present results suggest that there is no sexual difference in the effect of naloxone in the MPO and DBB on LH secretion. The difference in the effect on PRL secretion appeared very small, if any. It is not clear, however, whether the reported sexual difference in the preoptic opioid system is concerned solely with this small difference in the PRL secretion. It is rather likely that the greater number of opioid fibers and receptors in the female than in the male [5] [6] [7] [8] is somehow related to the extremely stronger opioid activity in the morning of proestrus than the afternoon and other stages [45] [46] [47] . This agrees with the lack of difference between the male and the female in diestrus in the efficacy of naloxone in inducing seizures. The efficacy is probably greater when the injection is done in the morning of proestrus.
It is surprising to notice that naloxone has been discussed in relation to GABA receptors in connection with the effect on behavioral seizures, but not the effect on anterior pituitary hormone secretion. Although the view regarding naloxone as a GABA antagonist has been obtained from results obtained with very high doses of naloxone, it seems necessary to pay attention to this in explaining the effect on anterior pituitary hormone secretion.
